# Preventing Microalbuminuria in Type 2 Diabetes

> **NCT00503152** · PHASE3 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 612 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Benazepril
- **DRUG:** Valsartan
- **DRUG:** Benazepril/Valsartan

## Key facts

- **NCT ID:** NCT00503152
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 612 (ACTUAL)
- **Last updated:** 2019-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503152, "Preventing Microalbuminuria in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00503152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*